EGFR and esophageal squamous cell carcinoma: It is reported that miR-1299 is able to modulate the function of the Akt-mTOR pathway via directly bind to the 3′-untranslated region of the upstream regulator, epidermal growth factor receptor (EGFR), thereby promoting the autophagic flux leading to inhibition of ESCC progression [55].